Gone are the days when a doctor’s only way of helping patients is by treating the disease after symptoms have started. Instead, a new approach to medicine, called “Desktop Medicine” is emerging, in which the emphasis shifts from diagnosing diseases and treating symptoms to identifying risk-factors for medical conditions such as hypertension and osteoporosis, and intervening before they develop. The commentary appears in the current issue of the Journal of the American Medical Association.
“Desktop medicine,” a model defined by Jason Karlawish, MD, Associate Professor of Medicine and Medical Ethics at the University of Pennsylvania School of Medicine, involves clinicians continuously gathering risk factor information – from a patient’s medical history, electronic medical records or recent office visit – and combining it with clinical studies about disease risk. Once the patient’s risk has been assessed, the physician can provide the appropriate intervention to prevent the onset of disease, rather than treat the disease once it is fully developed.
“Desktop medicine has substantial implications for how we ought to educate, train, and practice medicine,” said Dr. Karlawish. “For example, medical training should teach how to help patients appreciate their relevant risks and manage these risks, as many patients fail to adhere to a long-term intervention intended to prevent disease.”
This new model may also explain why primary care is suffering. Physicians need to learn how to incorporate both bedside and desktop medicine into an office visit, so long-term disease prevention is not overlooked while a short-term symptom is being addressed, and vice versa. Transformations in medical practice, such as electronic medical records, are also essential.
Medical and pre-medical education focused on epidemiology, genomics, and information sciences are increasingly important. Electronic medical records are crucial, as physicians use statistical models that require large sample sizes to detect risk. Both physicians and patients, who have increasing access to their own medical information, will have to learn how to collaborate on the decision making process. In addition, as new techniques are developed to change patient behaviors – such as payments for adhering to medications – physicians will need to learn how to talk with patients about these financial incentives.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.